Organization · Corporate Venture Capital
We Venture Capital
We Venture Capital is the corporate venture capital arm of Werfen, based in Barcelona, Spain. It invests in early-stage diagnostics startups and biotechnology companies focused on disrupting the diagnostics sector.
Overview
What We Venture Capital does
What We Venture Capital is
We Venture Capital is the corporate venture capital arm of Werfen, based in Barcelona, Spain. It invests in early-stage diagnostics startups and biotechnology companies focused on disrupting the diagnostics sector.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Corporate Venture Capital
- Founded
- Founded in 2023
- Approximate age
- About 3 years
- Structured capabilities
- Funder
- Last reviewed
- May 3, 2026
Official channels
Find We Venture Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
We Venture Capital as a funder
Investment thesis
We Venture Capital backs diagnostics startups, digital tools, life-science tools, and biotechnology companies that can transform diagnostics and improve patient outcomes. The firm prioritizes startups close to market entry or early market entrants ready to scale, leveraging Werfen’s specialized diagnostics expertise to provide strategic support, board engagement, networks, and long-term evergreen capital.
Focus narrative
We Venture Capital invests in diagnostics start-ups, digital solutions, and life science tools that aim to disrupt the diagnostics arena. The organization targets next-generation diagnostics and emerging biotech solutions, seeking companies with innovative technology that addresses clear clinical unmet needs. They provide strategic support and leverage a global network to maximize the chances of success for their portfolio companies.
Value beyond capital
We Venture Capital provides strategic support and leverages Werfen’s global network, scientific and technical expertise, and market access to maximize the chances of success for its portfolio companies.
Focus and fit
- Stages
- Seed · Series A · Series B
- Sectors
- Diagnostics · Digital Health · Biotech · Healthcare
- Regions
- Global
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 8
Portfolio context
Notable investments include Sepsis Diagnosis (Spain), Therapeutic Drug Monitoring (Belgium), Dried Blood Spot (Sweden), Genomics Tertiary Analysis (UK), Continuous Potassium Monitoring (Vancouver), Liquid Biopsy (Oxford), Whole Protein Sequencing (London), and Vital Sign Monitoring (Texas/Singapore).
Common questions
What to know about We Venture Capital
Upseed classifies We Venture Capital under the Corporate Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 3, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.